Previous close | 9.37 |
Open | 9.44 |
Bid | 9.15 x 200 |
Ask | 9.21 x 100 |
Day's range | 9.11 - 9.57 |
52-week range | 6.57 - 22.93 |
Volume | |
Avg. volume | 1,303,014 |
Market cap | 856.471M |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Rohan Palekar, CEO of 89bio Inc (NASDAQ:ETNB), executed a sale of 52,718 shares in the company on April 1, 2024, according to a recent SEC Filing.
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
Akero (AKRO) reports positive results from its mid-stage study of efruxifermin in pre-cirrhotic metabolic dysfunction-associated steatohepatitis patients at week 96. The stock gains 12%.